Brief: Redx Pharma Says Ongoing Phase 2 Clinical Studies Of RXC004 Will Open Enrolment Into Combination Arms
10/11/2022 17:10
Nov 10 (Reuters) - Redx Pharma PLC REDX.L :
* REDX PHARMA PLC - RXC004 PHASE 2 COMBINATION ARMS TO OPEN
ENROLMENT
* REDX PHARMA PLC - ONGOING PHASE 2 CLINICAL STUDIES OF
RXC004
WILL OPEN ENROLMENT INTO COMBINATION ARMS
Source text for Eikon: ID:nRSJ0283Ga
Further company coverage: REDX.L
((Reuters.Briefs@thomsonreuters.com;))